ADVANCED SOFT TISSUE SARCOMA
Clinical trials for ADVANCED SOFT TISSUE SARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOFT TISSUE SARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED SOFT TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare sarcoma: drug duo targets tumors
Disease control Recruiting nowThis study tests whether combining two drugs, atezolizumab and selinexor, can shrink tumors in people with a rare cancer called alveolar soft part sarcoma (ASPS). About 27 adults with advanced or spreading ASPS will receive the combination. The goal is to see if this approach wor…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for sarcoma patients: drug combo aims to shrink tumors
Disease control Recruiting nowThis study tests a new two-drug treatment for people with advanced soft tissue sarcomas (cancers of the muscles, fat, or other connective tissues). The drugs, abemaciclib and gemcitabine, work together to stop cancer cells from growing. The trial will compare this new combo to th…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Radioactive drug takes aim at Hard-to-Treat sarcoma
Disease control Recruiting nowThis early-phase trial is testing a radioactive drug called [Ac225]RTX-2358 in 30 adults with advanced soft tissue sarcoma that has come back or stopped responding to prior treatment. The drug is given as an IV injection once every 8 weeks for up to 6 doses. The main goals are to…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE1 • Sponsor: Ratio Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New x-ray activated drug injection tested for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial is testing a treatment called X-PACT for people with advanced head and neck cancer, breast cancer, soft tissue sarcoma, or melanoma that has not responded to standard treatments. X-PACT involves injecting a drug called methoxsalen directly into the tumor an…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE1 • Sponsor: Immunolight, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a chemo drug keep sarcoma at bay? new trial aims to find out
Disease control Recruiting nowThis Phase 2 trial tests whether a chemotherapy drug called pegylated liposomal doxorubicin (PLD) can help people with advanced soft tissue sarcoma live longer without their cancer growing. Participants who have already responded to standard chemotherapy will either receive PLD e…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
MRNA vaccine takes on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early study tests a new mRNA vaccine (IL-22BP) for people with advanced solid tumors like sarcoma, head and neck cancer, or melanoma that have not responded to standard treatments. The vaccine is injected directly into tumors. Only 6 participants are enrolled to check safety…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE1 • Sponsor: Xingchen Peng • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo aims to stall sarcomas in tough cases
Disease control Recruiting nowThis study tests two drugs, pembrolizumab and cabozantinib, together in people with advanced sarcomas (cancers of the soft tissue or bone) that have not responded to standard treatments. The goal is to see if the combination can stop or shrink tumors for at least 6 months. About …
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC